GlassScriptPhysician profile
Matthew J Chung
NPI 1063738011
$74,635.72
in general payments reported to CMS, 2019-2025
39 companies · $33K in 2025
The $33K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,355 · 2020: $2,400 · 2021: $7,517 · 2022: $3,559 · 2023: $7,269 · 2024: $16K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $26K · Consulting Fee: $12K · Travel and Lodging: $8,348 · Food and Beverage: $7,590 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,880 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $26,386.14 |
| Consulting Fee | $11,580.00 |
| Travel and Lodging | $8,348.12 |
| Food and Beverage | $7,590.02 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,880.00 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $46,773.41 | 2019-2025 | US Eq Undivided, Igt Devices Undivided, (7881) US Und |
| Abbott Laboratories | $6,080.88 | 2019-2025 | Triclip, Proclaim, Navitor |
| Edwards Lifesciences Corporation | $5,022.63 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque |
| Medtronic, INC. | $5,010.03 | 2021-2025 | Corevalve Evolut R, Ffrangio |
| W. L. Gore & Associates, INC. | $4,173.83 | 2021-2024 | Gore Cardioform Septal Occluder |
| Medtronic Vascular, INC. | $2,755.46 | 2019-2020 | |
| Boston Scientific Corporation | $1,090.77 | 2019-2023 | Watchman Flx |
| Abiomed | $791.77 | 2019-2024 | Impella |
| Shockwave Medical, INC | $282.41 | 2019-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $275.90 | 2021-2025 | Lifevest |
| Cardiovascular Systems INC. | $232.83 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $224.64 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $175.25 | 2022-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $174.89 | 2019-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $161.15 | 2020-2021 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $144.49 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.44 | 2020-2025 | Jardiance |
| Amgen INC. | $135.83 | 2019-2025 | Repatha |
| Integra Lifesciences Corporation | $128.32 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Angiodynamics, INC. | $100.71 | 2022-2023 | Alphavac |
| Astellas Pharma US INC | $92.00 | 2021-2024 | Veozah |
| Novo Nordisk INC | $89.51 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Penumbra, INC. | $89.09 | 2022-2025 | Penumbra System, Indigo System |
| Scpharmaceuticals INC. | $76.61 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $70.67 | 2023-2025 | Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $39.45 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $35.71 | 2024 | Uptravi, Opsumit |
| Amarin Pharma, INC. | $35.14 | 2019 | |
| Smith+Nephew, INC. | $29.59 | 2022 | |
| Cleerly, INC. | $27.60 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Kiniksa Pharmaceuticals International, Plc | $22.67 | 2024 | Arcalyst |
| Genzyme Corporation | $22.44 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $21.56 | 2025 | Evkeeza |
| Lexicon Pharmaceuticals, INC. | $19.90 | 2023 | Inpefa |
| Atricure, INC. | $19.59 | 2021 | |
| Cvrx, INC. | $19.18 | 2024 | Barostim Neo System |
| Esperion Therapeutics, INC. | $18.53 | 2022 | |
| Lemaitre Vascular, INC. | $14.84 | 2022 | |
| Bardy Diagnostics, INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.